Adial Pharmaceuticals Inc (ADIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 1,477 | 2,269 | 2,002 | 2,555 | 3,244 |
| Operating Income | -1,477 | -2,269 | -2,002 | -2,555 | -3,244 |
| Other Income | -33 | 29 | -98 | 3 | 7 |
| Pre-tax Income | -1,510 | -2,240 | -2,100 | -2,551 | -3,237 |
| Net Income Continuous | -1,510 | -2,240 | -2,100 | -2,551 | -3,237 |
| Net Income Discontinuous | 2,598 | -666 | -766 | -558 | -611 |
| Net Income | $1,088 | $-2,906 | $-2,867 | $-3,109 | $-3,848 |
| EPS Basic Total Ops | 24.00 | -68.75 | -62.00 | -75.50 | -99.00 |
| EPS Basic Continuous Ops | -33.25 | -53.00 | -45.75 | -62.00 | -83.25 |
| EPS Basic Discontinuous Ops | 57.50 | -15.75 | -19.00 | -13.50 | -15.75 |
| EPS Diluted Total Ops | 24.00 | -68.75 | -62.00 | -75.50 | -99.00 |
| EPS Diluted Continuous Ops | -33.25 | -53.00 | -45.75 | -62.00 | -83.25 |
| EPS Diluted Discontinuous Ops | 57.50 | -15.75 | -19.00 | -13.50 | -15.75 |
| EBITDA(a) | $-1,477 | $-2,269 | $-2,002 | $-2,555 | $-3,258 |